Browsing Tag
SARS-CoV-2 virus
21 posts
AstraZeneca strikes licensing deal with RQ Bio for SARS-CoV-2 targeting mAbs
AstraZeneca has signed a licensing deal with RQ Biotechnology (RQ Bio) to gain access to a portfolio of…
AstraZeneca gets UK MHRA approval for Evusheld for Covid-19 prevention
AstraZeneca said that its antibody combination Evusheld (tixagevimab co-packaged with cilgavimab) has been authorized by the UK Medicines…
Sorrento Therapeutics acquires majority stake in Zhengzhou FortuneBio
Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for…
Glenmark Pharmaceuticals launches Covid-19 treatment FabiSpray in India
Glenmark Pharmaceuticals and Canadian pharma company SaNOtize Research & Development Corp. have launched the latter’s Nitric Oxide Nasal…
Indian government approves use of Moderna’s Covid-19 Vaccine Moderna
US biotech company Moderna has been given emergency use authorization from the Indian government for its Covid-19 Vaccine…
DCGI gives emergency use approval for DRDO’s anti-COVID drug 2-DG
The Drugs Controller General of India (DCGI) has given emergency use approval for 2-deoxy-D-glucose (2-DG) of Defence Research…
CORAT begins COR-101 clinical trial in hospitalized Covid patients
CORAT Therapeutics said that it has begun a phase 1b/2 clinical trial of its antibody drug candidate COR-101…
Janssen Covid‑19 vaccine gets conditional marketing authorization in EU
The European Commission has granted a conditional marketing authorization (CMA) for the single dose Janssen Covid‑19 vaccine developed…
Cytocom gets FDA nod for phase 2 trial of Covid drug candidate CYTO-205
Cytocom has secured clearance from the US Food and Drug Administration (FDA) to undertake a phase 2 clinical…
FDA grants emergency use authorization to Janssen COVID-19 vaccine
The US Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the Janssen COVID-19…